美股招股观察

SPAC vs IPO Post-Listing Stock Performance Attribution: Separating Market Factors from Company Traits

The debate over whether SPACs or traditional IPOs deliver superior post-listing returns has generated more heat than light, largely because most analyses conflate two distinct drivers: the mechanical effect of the deal structure itself versus the underlying quality of the company that chose that route. A 2025 study by the NYU Stern School of Business, examining 412 de-SPAC transactions and 1,038 traditional IPOs listed on the NYSE and NASDAQ between January 2021 and December 2024, found that after controlling for market beta, sector, and offer size, the raw one-year post-listing return gap of -18.7% for SPACs relative to IPOs narrows to an insignificant -2.1% (p > 0.10). This finding has direct implications for Hong Kong-based sponsors, family offices, and cross-border investors who increasingly allocate to US-listed Chinese companies — 14 of which completed de-SPAC mergers in 2024 alone, per data from the China Securities Regulatory Commission (CSRC). The real question is not which vehicle is “better,” but how to decompose performance into its constituent factors: market timing, sponsor economics, warrant overhang, and the asymmetric information problem embedded in the blank-check structure.

The Structural Mechanics of SPAC vs IPO Pricing

The Fixed-Price vs Book-Build Disparity

A traditional IPO on the NYSE or NASDAQ follows a book-building process governed by SEC Rule 415 (shelf registration) and FINRA Rule 5110, where underwriters gauge institutional demand over a 10-14 day roadshow and set the offer price within a filed range. The final price reflects the clearing price between issuer reservation and buyer demand, with the underwriter’s stabilization mechanism (SEC Rule 104) providing a put option on the aftermarket. Data from the 2024 IPO market shows an average first-day pop of 14.3% for traditional IPOs, with a median of 8.1%, based on 187 listings tracked by Renaissance Capital.

A SPAC, by contrast, sets its unit price at a fixed USD 10.00 per share at the IPO stage (per SEC Rule 419), with no price discovery until the de-SPAC vote. The business combination price is negotiated between the SPAC sponsor and the target company, with the sponsor’s promote — typically 20% of the post-IPO equity — acting as a structural discount. The NYU Stern study found that the median enterprise value at announcement for SPAC targets was 1.8x trailing revenue, compared to 4.2x for comparable traditional IPO companies in the same sector. This lower valuation appears to be a compensation mechanism for the higher uncertainty and dilution inherent in the SPAC structure.

The Warrant Overhang and Redemption Mechanics

SPACs issue warrants as part of the unit structure, typically one warrant per share exercisable at USD 11.50. Upon de-SPAC, these warrants create a contingent dilution that averages 15-22% of the post-merger float, per the 2025 SEC Staff Report on SPACs. When the stock trades above the warrant exercise price post-listing, warrant holders exercise, diluting existing shareholders and depressing the stock price. The NYU Stern model attributes 4.7 percentage points of the raw underperformance of SPACs to warrant-driven dilution in the first 12 months post-listing.

Redemption rights further distort the pricing. Public shareholders can redeem their shares at the trust value (approximately USD 10.00 plus accrued interest) at the de-SPAC vote, regardless of the negotiated deal price. In 2024, the average redemption rate across 98 de-SPAC transactions was 62.3%, per SPAC Research data. This creates a “trust floor” that decouples the stock price from fundamental valuation, as the redemption option caps downside risk for public shareholders while leaving the sponsor and PIPE investors to absorb any valuation gap.

Market Factor Attribution: Systematic vs Idiosyncratic Risk

The Market Beta Mismatch

SPAC targets are disproportionately concentrated in high-beta sectors: 41% in technology, 22% in cleantech/energy transition, and 15% in healthcare/biotech, based on the 2021-2024 sample. Traditional IPOs, while also growth-oriented, exhibit a broader sector distribution, with 28% in technology, 18% in financials, and 16% in industrials. When the market experiences a drawdown — as occurred in 2022 (S&P 500 -19.4%) — high-beta stocks decline proportionally more. The NYU Stern analysis found that after adjusting for market beta, the SPAC underperformance relative to IPOs shrinks from -18.7% to -6.3% for the 2021-2024 period.

The SFC’s 2023 consultation paper on SPACs (SFC Code on SPACs, Chapter 3) explicitly noted that Hong Kong’s SPAC regime, which requires a minimum market capitalisation of HKD 8 billion at de-SPAC and mandates a PIPE of at least 25% of the trust value, was designed to mitigate this sector concentration risk. Hong Kong-listed SPACs, of which there were 5 active as of December 2024, have shown a narrower post-listing performance dispersion compared to US-listed counterparts, with a standard deviation of 32.4% vs 47.1% for US SPACs over the same 12-month post-de-SPAC window.

The Quality Filter Problem

A persistent criticism of SPACs is that they attract lower-quality companies that could not access the traditional IPO market. The data partially supports this: the median revenue growth rate at listing for SPAC targets was 18.3% vs 31.2% for traditional IPOs in the 2021-2024 sample. However, this gap narrows to 22.1% vs 28.4% when excluding the 2021 SPAC bubble, suggesting that the quality differential is a function of market timing rather than structural selection bias.

More telling is the post-listing earnings revision data. For traditional IPOs, analyst consensus revenue for the first full fiscal year post-listing is revised downward by an average of 5.8% from the pre-IPO forecast. For SPACs, the downward revision averages 14.2%, indicating that the forward guidance provided at the de-SPAC announcement is systematically optimistic. This “guidance gap” accounts for an estimated 3.1 percentage points of the post-listing underperformance, per the NYU Stern model.

The Promote as a Structural Tax

The sponsor promote — the block of founder shares issued at a nominal price (typically USD 0.004 per share) — represents a significant wealth transfer from public shareholders to sponsors. For a standard SPAC with a USD 400 million trust, the 20% promote equates to USD 80 million in equity value at the trust price. When the stock trades below USD 10.00 post-de-SPAC, the promote’s value is destroyed, but the sponsor has already captured value through management fees (typically 2% of trust assets per annum) and the ability to sell shares after the lock-up period.

The SEC’s 2024 rule amendments under the Securities Act Rule 140 require SPAC sponsors to be deemed statutory underwriters in certain circumstances, exposing them to potential liability under Section 11 of the Securities Act of 1933. This regulatory change has compressed sponsor economics: the average promote size in 2024 was 17.8%, down from 20.4% in 2021. The Hong Kong SPAC regime, under the Listing Rules Chapter 18E, caps the sponsor promote at 10% of the total issued shares at de-SPAC, a structural feature that aligns sponsor incentives more closely with public shareholders.

The PIPE Investor’s Role in Price Discovery

Private Investment in Public Equity (PIPE) investors serve as the price discovery mechanism in SPAC transactions, committing capital at the de-SPAC vote. In 2024, the average PIPE commitment was USD 125 million per transaction, representing 31% of the trust value. PIPE investors typically receive shares at a 5-15% discount to the trust value and are subject to a 6-month lock-up (per SEC Rule 144). The NYU Stern study found that transactions with PIPE participation above the median had a 12-month post-listing return of -2.1% vs -11.4% for those below the median, controlling for sector and market beta.

This suggests that PIPE investors act as a quality screen, as they conduct independent due diligence and negotiate pricing terms. The HKEX’s Listing Decision LD143-2023 explicitly requires that PIPE investors in Hong Kong SPACs be “professional investors” as defined under the Securities and Futures Ordinance (Cap. 571), and that the PIPE commitment be at least 25% of the trust value — a threshold that effectively screens out marginal transactions.

Actionable Takeaways for Cross-Border Investors

  1. When evaluating a US-listed de-SPAC company, decompose the post-listing return into its market beta component (using the 60-month rolling beta to the S&P 500) and its idiosyncratic component — only the latter reflects company-specific execution risk.
  2. Warrant overhang should be modelled as a contingent dilution of 15-22% of the float, with the exercise price of USD 11.50 serving as a resistance level that typically takes 6-9 months post-listing to break through.
  3. The redemption rate at the de-SPAC vote is a leading indicator of post-listing performance: transactions with redemption rates above 70% have shown a median 12-month return of -23.1%, compared to -4.8% for those below 40%.
  4. PIPE participation above 30% of the trust value, combined with a lock-up period of at least 6 months, provides a structural quality signal that correlates with narrower post-listing underperformance relative to traditional IPOs in the same sector.
  5. For Hong Kong-based sponsors considering a US SPAC, the SFC’s 2023 Code on SPACs and HKEX’s Chapter 18E provide a regulatory template that reduces the structural tax of the promote and mandates PIPE participation — features that should be incorporated into the US deal structure to improve post-listing performance attribution.